Hepatite viral C: um estudo da mortalidade e das causas múltiplas de morte : Viral hepatitis C: a study of mortality and multiple-cause-of-death

Vanessa  Cavalcante de Sena; Ana Claudia  Morais Godoy Figueiredo; Maria Regina  Fernandes de Oliveira

doi:10.17765/2176-9206.2024v17n4.e12293

Authors

Vanessa Cavalcante de Sena State Health Department of the Federal District https://orcid.org/0009-0004-2244-1525
Ana Claudia Morais Godoy Figueiredo State Health Department of the Federal District https://orcid.org/0000-0003-2842-9848
Maria Regina Fernandes de Oliveira University of Brasília https://orcid.org/0000-0002-4995-2526

DOI:

https://doi.org/10.17765/2176-9206.2024v17n4.e12293

Keywords:

Viral Hepatitis C, Mortality, Multiple causes of death

Abstract

Objective: To describe the deaths recorded on death certificates mentioning hepatitis C among residents in the Federal District between 2006 and 2020. Methods: This descriptive epidemiological study used official, non-nominal databases of the Mortality Information System (Sistema de Informação sobre Mortalidade). Data analysis was performed with TabWin, Microsoft Excel, and Stata software, alongside population estimates from the Planning Company of the Federal District (Companhia de Planejamento do Distrito Federal). Trend analysis was conducted using Prais-Winsten linear regression. Results: Between 2006 and 2020, 487 deaths mentioning hepatitis C were recorded. Among these, 229 (47.0%) listed hepatitis C as the underlying cause, while 258 (53.0%) identified hepatitis C solely as an associated cause. The overall mortality rates for hepatitis C and the adjusted mortality rates (hepatitis C + hepatocellular carcinoma) showed stationary trends. Conclusion: Hepatitis C was underreported as the underlying cause of death. This underscores the need for professional training and a review of the criteria used to determine the underlying cause of mortality.

Downloads

Download data is not yet available.

Author Biographies

Vanessa Cavalcante de Sena, State Health Department of the Federal District

Nurse, Master in Tropical Medicine in the area of Epidemiology and Control of Infectious and Parasitic Diseases, public servant at the State Health Department of the Federal District, working in death surveillance.

Ana Claudia Morais Godoy Figueiredo, State Health Department of the Federal District

Graduated in Nursing from the Federal University of Vale do São Francisco - Univasf (2007-2010). Master's degree in Public Health from the State University of Feira de Santana - UEFS (2011-2013). PhD in Health Sciences from the University of Brasília - UnB (2014-2018). Post-doctorate in Public Health (Epidemiology) from the University of Brasília (2018-2019), currently develops research in the area of Epidemiology and Scientific Communication with the Center for Epidemiology and Health (UFRB). He works with systematic review and meta-analysis for decision making, in the Epidemiological Surveillance of the State Secretariat of Health of the Federal District with management of health information, mortality indicators, in the Teaching Nucleus of the Multiprofessional Residency Program in Management of Public Policies for Health of the Foundation for Teaching and Research in Health Sciences (FEPECS), in the teaching staff of the Professional Master's Program in Family Health (ProfSaúde) of the Federal University of Recôncavo da Bahia (UFRB) and in the Academic Master's Program in Health Sciences of the Higher School of Health Sciences (ESCS).

Maria Regina Fernandes de Oliveira, University of Brasília

Graduated in Medicine from the Federal University of Pará - UFPA (1985), master's degree in Tropical Medicine from the Center for Tropical Medicine at the University of Brasília - UnB (1994) and PhD in Public Health, with a concentration in Epidemiology, from the School of Public Health at the University of São Paulo - FSP/USP (2009). Doctoral thesis project on cost-effectiveness analysis of rapid testing for the diagnosis of malaria. From 1998 to 2009, she was General Coordinator of the Area of Development of Epidemiology in Services, initially linked to CENEPI/Funasa and later to the Health Surveillance Secretariat of the Ministry of Health. Since 2010, she has been a professor at the School of Medicine at the University of Brasília as an associate professor in the epidemiology subarea of Social Medicine and a researcher in the Postgraduate Program in Tropical Medicine, in the area of concentration Epidemiology and Control of Infectious and Parasitic Diseases. Interests: Infectious and Parasitic Diseases, with a focus on illness and death; diagnosis; technology assessment; and economic evaluation.

References

Ministério da Saúde. Hepatite C [Internet]. [cited 2023 Jan 9]. Available from: https://www.gov.br/aids/pt-br/assuntos/hepatites-virais/hepatite-c#:~:text=Hepatite C%2C.

Li H, Huang M-H, Jiang J-D, Peng Z-G. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World J Gastroenterol [Internet]. 2018;24(47):5297–311. https://doi.org/10.3748%2Fwjg.v24.i47.5297.

Ministério da Saúde. Protocolo clínico e diretrizes terapêuticas para hepatite C e coinfecções [Internet]. 2019. 68 p. Available from: http://www.aids.gov.br/pt-br/pub/2017/protocolo-clinico-e-diretrizes-terapeuticas-para-hepatite-c-e-coinfeccoes.

Diaz-Soto MP, Garcia-Tsao G. Management of varices and variceal hemorrhage in liver cirrhosis: a recent update. Therap Adv Gastroenterol. 2022;15(X):1–12. https://doi.org/10.1177/17562848221101712.

Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014 Nov 1;61(1):S58–68. https://doi.org/10.1016/j.jhep.2014.07.012.

Veracruz N, Gish RG, Cheung R, Chitnis AS, Wong RJ. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019. J Viral Hepat. 2022; 29:352–365. https://doi.org/10.1111/jvh.13663.

Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Boletim Epidemiológico. Hepatites Virais 2023. Brasília; 2023. Número especial.

Laurenti R. A análise da mortalidade por causa básica e por causas múltiplas. Rev Saude Publica 1974; 8(4):421–35. https://doi.org/10.1590/S0034-89101974000400008.

Organização Mundial de Saúde. CID-10. Tradução Centro Colaborador da OMS para a Família de Classificações Internacionais em Português - 8. ed. rev. e ampl., 3a reimp. - São Paulo: Editora da Universidade de São Paulo, 2018. 10a Revisão. V. 2.

Laurenti R, Jorge MHP de M. Atestado de óbito: aspectos médicos, estatísticos, éticos e jurídicos [Internet]. Conselho Regional de Medicina do Estado de São Paulo. São Paulo; 2015. 154 p. Available from: http://www.cremesp.org.br/pdfs/atestado_de_obito.pdf.

Martins RC, Buchalla CM. Codificação e seleção automáticas das causas de morte : adaptação para o uso no Brasil do software Iris. Rev. Bras. Epidemiol. 2015;18(4):883–93. https://doi.org/10.1590/1980-5497201500040016.

Laurenti R, Buchalla CM. A elaboração de estatísticas de mortalidade segundo causas múltiplas. Rev Bras Epidemiol. 2000; 3(1–3):21–8. https://doi.org/10.1590/S1415-790X2000000100003.

Rezende EM, Ishitani LH, Santo AH, Martins EF. Mortalidade Relacionada À Insuficiência Renal Crônica No Brasil: Um Estudo Usando Causas Múltiplas De Morte. Rev Ibero-Americana Humanidades, Ciências e Educ. 2021;7(4):29–38. http://dx.doi.org/10.51891/rease.v7i4.941.

Santo AH, Pinheiro CE. Reavaliação do Potencial Epidemiológico das Causas Múltiplas de Morte no Brasil, 2015. Rev Ibero-Americana Humanidades, Ciências e Educ. 2022;8(1):1620–39. http://doi.org/10.51891/rease.v8i1.4008.

Secretaria de Saúde do Distrito Federal. Informativo Epidemiológico das Hepatites virais B, C e D no Distrito Federal entre 2017 a 2021. Secretaria de Saúde do Distrito Federal, editor. Brasília; 2022. 31 p.

Secretaria de Saúde do Distrito Federal. Informe epidemiológico. Secretaria de Saúde do Distrito Federal, editor. Brasília; 2021. 28 p.

Ministério da Saúde. Boletim Epidemiológico Hepatites Virais 2021. Brasília; 2021. 84 p.

Ripsa. Indicadores básicos para a saúde no Brasil: conceitos e aplicações. 2a. ed. Organização Pan Americana da Saúde, editor. Brasília; 2008. 349 p.

Ishitani LH, França E. Uso das causas múltiplas de morte em saúde pública. Inf Epidemiológico do Sus. 2001;10(4):163–75. http://dx.doi.org/10.5123/S0104-16732001000400003.

Meyers DJ, Hood ME, Stopka TJ. HIV and Hepatitis C Mortality in Massachusetts, 2002–2011: Spatial Cluster and Trend Analysis of HIV and HCV Using Multiple Cause of Death. PLoS ONE. 2014; 9(12): e114822. https://doi.org/10.1371/journal.pone.0114822.

Sehdev AES, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161(2):277–84. https://doi:10.1001/archinte.161.2.277.

Ly KN, Xing J, Klevens RM, Jiles RB, Holmberg SD. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis. 2014;58(1):40–9. https://doi:10.1093/cid/cit642.

Mahale P, Torres HA, Kramer JR, Hwang LY, Li R, Brown EL, et al. Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study. Cancer. 2017; 123(7):1202–11. https://doi.org/10.1002/cncr.30559.

Mincis M, Mincis R. Álcool e o Fígado. Rev GED - Gastroentereologia Endosc Dig. 2011;30(4):152–62.

Shoreibah M, Anand BS, Singal AK. Alcoholic hepatitis and concomitant hepatitis C virus infection. World J Gastroenterol. 2014; 20(34):11929–34. https://doi.org/10.3748%2Fwjg.v20.i34.11929.

Tsui JI, Pletcher MJ, Vittinghoff E, Seal K, Gonzales R. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol. 2006;44(2):262–6. https://doi.org/10.1016/j.jhep.2005.07.027.

Henry JA, Moloney C, Rivas C, Goldin RD. Increase in alcohol related deaths: is hepatitis C a factor? J Clin Pathol. 2002; 55(9):704–7. https://doi.org/10.1136%2Fjcp.55.9.704.

Singal AK, Sagi S, Kuo YF, Weinman S. Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis. Eur J Gastroenterol Hepatol. 2011; 23(3):204–9. https://doi.org/10.1097/meg.0b013e328343b085.

World Health Organization. Interim Guidance for Country Validation of Viral Hepatitis Elimination. 2021. 96 p.

World Health Organization. Global health sector strategy on viral hepatitis 2016-2021. Glob Hepat Program Dep HIV/AIDS. 2016;(June):56.

Ministério da Saúde. Brasil avança no combate à hepatite C. [Internet]. 2020 [cited 2023 Mar 29].

Li DK, Chung RT. Impact of hepatitis C virus eradication on hepatocellular carcinogenesis. Cancer. 2015; 121(17):2874–82. https://doi.org/10.1002%2Fcncr.29528.

Axley P, Ahmed Z, Ravi S, Singal AK. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. J Clin Transl Hepatol. 2018;6(1):79. https://doi.org/10.14218%2FJCTH.2017.00067.

de Brito RJVC, da Silva LF, Santos MB, de Moura PMMF, de Souza CDF, do Carmo RF. A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018. BMC Infectious Diseases. 2022; 22:81. https://doi.org/10.1186/s12879-022-07063-5.

Viral hepatitis C: a study of mortality and multiple-cause-of-death